77 related articles for article (PubMed ID: 2119527)
1. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region.
Tranquille N; Emeis JJ
Thromb Haemost; 1990 Jun; 63(3):454-8. PubMed ID: 2119527
[TBL] [Abstract][Full Text] [Related]
2. On the role of calcium in the acute release of tissue-type plasminogen activator and von Willebrand factor from the rat perfused hindleg region.
Tranquille N; Emeis JJ
Thromb Haemost; 1991 Oct; 66(4):479-83. PubMed ID: 1724576
[TBL] [Abstract][Full Text] [Related]
3. Adenosine diphosphate stimulates the endothelial release of tissue-type plasminogen activator but not von Willebrand factor from isolated-perfused rat hind limbs.
Smalley DM; Fitzgerald JE; O'Rourke J
Thromb Haemost; 1993 Dec; 70(6):1043-6. PubMed ID: 8165598
[TBL] [Abstract][Full Text] [Related]
4. The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor.
Tranquille N; Emeis JJ
Thromb Haemost; 1993 Mar; 69(3):259-61. PubMed ID: 8097063
[TBL] [Abstract][Full Text] [Related]
5. Protein synthesis inhibition by cycloheximide does not affect the acute release of tissue-type plasminogen activator.
Tranquille N; Emeis JJ
Thromb Haemost; 1989 Jun; 61(3):442-7. PubMed ID: 2508256
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 and -3 induce the release of tissue-type plasminogen activator and von Willebrand factor from endothelial cells.
Pruis J; Emeis JJ
Eur J Pharmacol; 1990 Oct; 187(1):105-12. PubMed ID: 2125563
[TBL] [Abstract][Full Text] [Related]
7. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease.
Wieczorek I; Ludlam CA; MacGregor IR
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):329-34. PubMed ID: 8075304
[TBL] [Abstract][Full Text] [Related]
8. The involvement of products of the phospholipase pathway in the acute release of tissue-type plasminogen activator from perfused rat hindlegs.
Tranquille N; Emeis JJ
Eur J Pharmacol; 1992 Mar; 213(2):285-92. PubMed ID: 1521562
[TBL] [Abstract][Full Text] [Related]
9. Sympathoadrenal activation and muscarinic receptor stimulation induce acute release of tissue-type plasminogen activator but not von Willebrand factor across the human forearm.
Jern C; Selin L; Tengborn L; Jern S
Thromb Haemost; 1997 Aug; 78(2):887-91. PubMed ID: 9268190
[TBL] [Abstract][Full Text] [Related]
10. On the role of bradykinin in secretion from vascular endothelial cells.
Emeis JJ; Tranquille N
Agents Actions Suppl; 1992; 38 ( Pt 2)():285-91. PubMed ID: 1334333
[TBL] [Abstract][Full Text] [Related]
11. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
12. The effect of pentoxifylline (Trental) and two analogues, BL 194 and HWA 448, on the release of plasminogen activators and von Willebrand factor in rats.
Tranquille N; Emeis JJ
J Cardiovasc Pharmacol; 1991 Jul; 18(1):35-42. PubMed ID: 1719289
[TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6.
Newby DE; Stewart A; Witherow FN; Grieve S; Dawson P; Fox KA; Webb DJ; Ludlam CA
Thromb Haemost; 2000 Aug; 84(2):195-203. PubMed ID: 10959689
[TBL] [Abstract][Full Text] [Related]
15. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
16. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
[TBL] [Abstract][Full Text] [Related]
17. [Change of vWF, PAl-1 and t-PA in rats with hyperlipemia and its significance].
Jiang HH; Liu Y; Lin GQ; Li YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):415-20. PubMed ID: 18544845
[TBL] [Abstract][Full Text] [Related]
18. Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells.
van den Eijnden-Schrauwen Y; Atsma DE; Lupu F; de Vries RE; Kooistra T; Emeis JJ
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2177-87. PubMed ID: 9351387
[TBL] [Abstract][Full Text] [Related]
19. Enhanced vascular plasminogen activator (t-PA) release by epinephrine in aged rats.
Iacoviello L; D'Adamo MC; De Curtis A; Buczko W; Donati MB
Thromb Haemost; 1995 May; 73(5):841-4. PubMed ID: 7482413
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological stimulation of t-PA release.
Klöcking HP; Markwardt F
Pharmazie; 1994 Apr; 49(4):227-30. PubMed ID: 7910971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
